Skip to main content

Hunting Hill Global Capital, LLC

Position in ABVX — Abivax S.A.

CIK 1697398 New York, NY

Position in ABVX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$308,996
New position
Shares Held
2,775
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Derivatives in ABVX

reported options exposure · as of Mar 31, 2026
CallValue
$2,672,400
CallShares
24,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Hunting Hill Global Capital, LLC holds $1,495,206 across 4 Biotechnology names. ABVX ranks #2 (20.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABVX
Abivax S.A.
This page
2,775 $308,996

All Filings in ABVX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $308,996 2,775
2026-03-31 $2,672,400 24,000